Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency

The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian... Purpose To evaluate the effect of 12-month DHEA supplementation on menstrual pattern and ovarian reserve markers in women with premature ovarian insufficiency (POI) Methods This is a prospective observational study. Women with POI were given DHEA supplements (25 mg three times daily) for 12 months. Sonographic assessment for ovarian volume and antral follicle count (AFC) and serum measurement for anti- Mullerian hormone (AMH), follicle stimulating hormone (FSH), estradiol, testosterone, liver function, and hemoglobin level were performed at baseline and monthly for 13 months after the supplementation. Menstrual pattern, ovarian reserve markers, and side-effects were recorded. Results Between August 2011 and July 2014, 38 women with POI were recruited and 31 completed the study. The median age of women was 36 years, and the median baseline FSH and AMH concentrations were 82.2 IU/L and 0.01 ng/ml, respectively. No women had resumption of regular menstruation after DHEA supplementation. AMH, FSH, and AFC did not change signifi- cantly. No serious side effects were reported. Conclusions Our results do not support any significant improvement in ovarian function by 12-month DHEA supplementation in women with POI. . . . . Keywords Dehydroepiandrosterone Premature ovarian insufficiency Anti-Mullerian hormone Follicle-stimulating hormone Antral follicle count Introduction diagnosed http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Assisted Reproduction and Genetics Springer Journals

The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency

Loading next page...
 
/lp/springer_journal/the-effect-of-12-month-dehydroepiandrosterone-supplementation-on-the-10846AqD97

References (22)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Gynecology; Reproductive Medicine; Human Genetics
ISSN
1058-0468
eISSN
1573-7330
DOI
10.1007/s10815-018-1152-2
pmid
29520734
Publisher site
See Article on Publisher Site

Abstract

Purpose To evaluate the effect of 12-month DHEA supplementation on menstrual pattern and ovarian reserve markers in women with premature ovarian insufficiency (POI) Methods This is a prospective observational study. Women with POI were given DHEA supplements (25 mg three times daily) for 12 months. Sonographic assessment for ovarian volume and antral follicle count (AFC) and serum measurement for anti- Mullerian hormone (AMH), follicle stimulating hormone (FSH), estradiol, testosterone, liver function, and hemoglobin level were performed at baseline and monthly for 13 months after the supplementation. Menstrual pattern, ovarian reserve markers, and side-effects were recorded. Results Between August 2011 and July 2014, 38 women with POI were recruited and 31 completed the study. The median age of women was 36 years, and the median baseline FSH and AMH concentrations were 82.2 IU/L and 0.01 ng/ml, respectively. No women had resumption of regular menstruation after DHEA supplementation. AMH, FSH, and AFC did not change signifi- cantly. No serious side effects were reported. Conclusions Our results do not support any significant improvement in ovarian function by 12-month DHEA supplementation in women with POI. . . . . Keywords Dehydroepiandrosterone Premature ovarian insufficiency Anti-Mullerian hormone Follicle-stimulating hormone Antral follicle count Introduction diagnosed

Journal

Journal of Assisted Reproduction and GeneticsSpringer Journals

Published: Mar 9, 2018

There are no references for this article.